Abstract
It is clear that the optimal clinical outcomes in bladder cancer patients requiring radical cystectomy are related to standard histopathologic variables of tumor grade, stage and lymph node status. However, other less well defined variables are also critical to the successful outcomes of these patients. Patients with muscle invasive bladder cancer and treating physicians should avoid unnecessary and significant treatment delays. In addition, hospital and surgeon-volume/experience are thought to be factors that may too be important components that relate to the clinical outcomes of patients following surgery. Lastly, there is a growing body of literature to support the concept of an appropriate lymphadenectomy at the time of surgery, for both node-positive and node-negative bladder cancer patients. It is becoming more obvious that there are multiple variables involved in the clinical success and outcomes of patients with bladder cancer following radical cystectomy. As treating physicians and surgeons we must be aware of these components to ensure the best outcomes for our patients.
Similar content being viewed by others
References
Jamal A, Taylor M, Ward E et al (2005) Cancer statistics 2005. CA Cancer J Clin 55:10–20
Prout G, Marshall VF (1956) The prognosis with untreated bladder tumors. Cancer 9:551–558
Sanchez-Ortiz RF, Huang W, Mick R, Van Arsdalen KN, Wein AJ, Malkowicz SB (2003) An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 169:110–115
Lee CT, Madii R, Daignault S, Dunn RL, Zhang Y, Montie JE, Wood DP Jr. (2006) Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J Urol 175:1262–1267
Hautmann RE, Paiss T (1998) Does the option of the ileal neobladder stimulate patient and physician decision toward earlier cystectomy? J Urol 159:1845–1850
Chang SS, Hassan M, Cookson MS, Wells N, Smith JA Jr (2003) Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 170:1085–1087
Muhmud SM, Fong B, Fahmy N, Tanguay S, Aprikian AG (2006) Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study. J Urol 175:78–83
Liedberg F, Anderson H, Mansson W (2005) Treatment delay and prognosis in invasive bladder cancer. J Urol 174:1777–1781
Wiesner C, pfitzenmaier J, Faldum A, Gillitzer R, Melchior SW, Thuroff JW (2005) Lymph node metastases in non-muscle invasive bladder cancer are correlated with the number of transurethral resections and tumour upstaging at radical cystectomy. BJU Int 95:301–305
May M, Nitzke T, Helke C, Vogler H, Hoschke B (2004) Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. Scand J Urol Nephrol 38:231–235
Herr HW (2005) Surgical factors in the treatment of superficial and invasive bladder cancer. Urol Clin North Am 32:157–164
Lange PH, Lin DW (2004) Does the who and how of surgery in bladder cancer matter. J Clin Oncol 22:2762
Stein JP, Lieskovsky G, Cote R, Groshen S, Feng A-C, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 19:666–675
Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128–1137
Birkmeyer JD, Sun Y, Goldfaden A, Birkmeyer NJO, Stukel TA (2006) Volume and process of care in high-risk cancer surgery. Cancer 106:2476–2481
Begg CB, Reidel ER, Bach PB et al (2002) Variations in morbidity after radical prostatectomy. N Engl J Med 346:1138–1144
Dimick J, Pronovost P, Cowan JA, Lipsett P, Stanley J, Upchurch GJ (2003) Variation in postoperative complication rates after high-risk surgery in the United States. Surgery 134:534–540
Elting LS, Pettaway C, Bekele BN, Grossman BH, Cooksley C, Avritscher EBC, Dinney CP (2005) Correlation between annual volume of cystectomy, professional staffing and outcomes. Cancer 104:975–984
Konty BR, Allareddy V, Modak S, Smith B (2006) Mortality after major surgery for urologic cancers in specialized urologic hospital: are they any better? J Clin Oncol 24:2006–2012
Birkmeyer J, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349:2117–2127
Herr H, Lee C, Chang S, Lerner S (2004a) For the Bladder Cancer Collaborative Group: Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer; a collaborative group report. J Urol 171:1823–1828
McCabe JE, Jibawi A, Javle P (2005) Defining the minimum hospital case-load to achieve optimum outcomes in radical cystectomy. BJU Int 96:806–810
National Institute of Clinical Excellence(2003) Draft, Urologic Cancer Standards: manual of cancer services standards. National Institute of Clinical Excellence, London
Herr HW, Faulkner JR, Grossman HB, Natale RB, White RD, Sarosdy MF, Crawford ED (2004) Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 22:2781–2789
Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL et al (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349:859–866
Barth PJ, Gerharz EW, Ramaswamy A et al (1999) The influence of lymph node counts on the detection of pelvic lymph node metastasis in prostate cancer. Pathol Res Pract 195:633–636
Terrone C, Guercio S, DeLuca S, Poggio M, Castelli E, Scoffone C, Tarabuzzi R, Scarpa RM, Fontana D, Rossetti SR (2003) The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int 91:37–40
Stein JP, Quek ML, Skinner DG (2006) Lymphadenectomy for invasive bladder cancer: I. Historical perspective and contemporary rationale. BJU Int 97:227–231
Stein JP, Quek ML, Skinner DG (2006) Lymphadenectomy for invasive bladder cancer. II. Technical aspects and prognostic factors. BJU Int 97:232–237
Stein JP (2003) Indications for early cystectomy. Urology 62:591–595
Leissner J, Ghoneim MA, Abol-Enein H, Thuroff JW, Franzaring L, Fisch M, Schulze H et al (2004) Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 171:139–144
Poulsen AL, Horn T, Steven K (1998) Radical cystectomy; extending limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 160:2015–2020
Vieweg J, Gschwend JE, Herr HW, Fair WR (1999) The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol 161:72–76
Leissner J, Hohenfellner R, Thuroff JW, Wolf HK (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 85:817–823
Vazina A, Dugi D, Shariat SF, Evans J, Link R, Lerner SP (2004) Stage specific lymph node metastasis mapping in radical cystectomy specimens. J Urol 171:1830–1834
Abdel-Latif M, Abol-Enein H, El-Baz M, Ghoneim MA (2004) Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol 172:85–89
Smith JA, Whitmore WF Jr (1981) Regional lymph node metastasis from bladder cancer. J Urol 126:591–593
Bochner BH, Cho C, Herr HW, Donat M, Kattan MW, Dalbagni G (2004) Prospective packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J Urol 172:1286–1290
Brossner C, Pycha A, Toth A, Mian C, Kuber W (2004) Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int 93:64–66
Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295–1298
Konety BR, Joslyn SA, O’Donnell MA (2003) Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the surveillance, epidemiology and end results program data base. J Urol 169:945–950
Acknowledgments
This article is supported by an unrestricted Educational Grant from Marylyn and Neil Clark Warren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stein, J.P. Improving outcomes with radical cystectomy for high-grade invasive bladder cancer. World J Urol 24, 509–516 (2006). https://doi.org/10.1007/s00345-006-0111-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-006-0111-1